Apeiron Investment Group

Total investments

32

Average round size

50M

Portfolio companies

19

Rounds per year

2.91

Lead investments

6

Follow on index

0.41

Exits

5

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologyE-CommerceInternetHealth CareHealth DiagnosticsMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Summary

The leading representative office of defined VC is situated in the Sliema. The company was established in Europe in Malta.

The top activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund. The average startup value when the investment from Apeiron Investment Group is 10-50 millions dollars. Speaking about the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year.

We can highlight the next thriving fund investment areas, such as E-Commerce, Finance. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline Springlane, Juvenescence, Zenhomes For fund there is no match between the country of its foundation and the country of its the most frequent investments - Germany.

The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Apeiron Investment Group, startups are often financed by Heliad Equity Partners, HV Holtzbrinck Ventures, TEV | Tengelmann Ventures. The meaningful sponsors for the fund in investment in the same round are Christian Angermayer, main incubator, Valar Ventures. In the next rounds fund is usually obtained by Longevity Vision Fund, IPGL, Grok Ventures.

The current fund was established by Christian Angermayer.

Show more

Investments analytics

Analytics

Total investments
32
Lead investments
6
Exits
5
Rounds per year
2.91
Follow on index
0.41
Investments by industry
  • Biotechnology (17)
  • Health Care (12)
  • Life Science (12)
  • Therapeutics (9)
  • Biopharma (6)
  • Show 28 more
Investments by region
  • Germany (13)
  • United States (10)
  • United Kingdom (3)
  • Latvia (1)
  • Switzerland (2)
  • Show 1 more
Peak activity year
2021
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Avg. valuation at time of investment
130M
Group Appearance index
0.97
Avg. company exit year
4
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Ksana Health 16 Jun 2021 Health Care, Apps, Medical Seed 2M United States, Oregon, Eugene
Rejuveron Life Sciences 13 Sep 2023 Biotechnology, Health Care, Medical Early Stage Venture 75M Switzerland, Zurich

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.